|
Q2 FY2026
As of Jun 27, 2026
|
Q1 FY2026
As of Mar 28, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 27, 2025
|
Q2 FY2025
As of Jun 28, 2025
|
Q1 FY2025
As of Mar 29, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 28, 2024
|
Q2 FY2024
As of Jun 29, 2024
|
Q1 FY2024
As of Mar 30, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jul 1, 2023
|
Q1 FY2023
As of Apr 1, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Oct 1, 2022
|
Q2 FY2022
As of Jul 2, 2022
|
Q1 FY2022
As of Apr 2, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Oct 2, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Trade receivables, net | ||||||||||||||||||||
| Gross inventories (Note 4) | ||||||||||||||||||||
| Less LIFO reserve | ||||||||||||||||||||
| Less excess and obsolescence reserve | ||||||||||||||||||||
| Net inventories | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property, plant and equipment | ||||||||||||||||||||
| Less allowances for depreciation | ||||||||||||||||||||
| Net property, plant and equipment | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Trade accounts payable and accrued expenses | ||||||||||||||||||||
| Contract liabilities with customers (Note 3) | ||||||||||||||||||||
| Product liability | ||||||||||||||||||||
| Employee compensation and benefits | ||||||||||||||||||||
| Workers’ compensation | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Lease liabilities (Note 5) | ||||||||||||||||||||
| Employee compensation | ||||||||||||||||||||
| Product liability accrual | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Common Stock, Value | ||||||||||||||||||||
| Common Stock | ||||||||||||||||||||
| Total common Stock, Value | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Less: Treasury stock – at cost | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Equity | ||||||||||||||||||||
Loading...
